Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Ubiquitin C-terminal hydrolase UCHL5 (UCH37) deubiquitinates...
| Class:Id | Summation:2179297 |
|---|---|
| _displayName | Ubiquitin C-terminal hydrolase UCHL5 (UCH37) deubiquitinates... |
| _timestamp | 2012-04-16 20:59:00 |
| created | [InstanceEdit:2179296] Orlic-Milacic, M, 2012-04-03 |
| literatureReference | [LiteratureReference:2179288] The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling [LiteratureReference:2179322] USP15 stabilizes TGF-? receptor I and promotes oncogenesis through the activation of TGF-? signaling in glioblastoma |
| modified | [InstanceEdit:2179334] Orlic-Milacic, M, 2012-04-03 [InstanceEdit:2179335] Orlic-Milacic, M, 2012-04-03 [InstanceEdit:2197664] Orlic-Milacic, M, 2012-04-13 [InstanceEdit:2197821] Orlic-Milacic, M, 2012-04-16 [InstanceEdit:2199157] Orlic-Milacic, M, 2012-04-16 |
| text | Ubiquitin C-terminal hydrolase UCHL5 (UCH37) deubiquitinates TGFBR1, stabilizing TGF-beta receptor complex and prolonging TGF-beta receptor signaling. Deubiqutination of SMAD7 by UCHL5 has not been examined in this context (Wicks et al. 2005). Ubiquitin peptidase USP15 also deubiquitinates and stabilizes TGFBR1, leading to enhanced signaling by TGF-beta receptor complex. USP15 does not affect the ubiquitination status of SMAD7. Amplification of USP15 has recently been reported in glioblastoma, breast and ovarian cancer. In advanced glioblastoma, TGF-beta receptor signaling acts as an oncogenic factor, and USP15-mediated upregulation of TGF-beta receptor signaling may be a key factor in glioblastoma pathogenesis (Eichhorn et al. 2012). The role of UCHL5 was inferred from experiments using recombinant mouse Uchl5 and Smad7 with recombinant human TGF-beta receptors. The role of USP15 was established by experiments using human proteins. |
| (summation) | [Reaction:2179291] UCHL5, USP15 deubiquitinate TGFBR1 [Homo sapiens] [Reaction:9846260] GOCAM UCHL5, USP15 deubiquitinate TGFBR1 [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Ubiquitin C-terminal hydrolase UCHL5 (UCH37) deubiquitinates... (2179297)
